Full Text View
Tabular View
No Study Results Posted
Related Studies
Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles
This study has been terminated.
( Lower than anticipated recruitment )
Study NCT01007851   Information provided by V.K.V. American Hospital, Istanbul

First Received on November 3, 2009.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infertility
More general conditions related to this trial
Genital Diseases, Female
Genital Diseases, Male
Interventions listed in this trial
triptorelin acetate
NaCl %0.9
Additional drug interventions recognized in this trial
Triptorelin
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Contraceptive Agents
Contraceptive Agents, Female
Luteolytic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
V.K.V. American Hospital, Istanbul


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services